Literature DB >> 3436136

Allergic contact dermatitis of the face from contact with nickel and ammoniated mercury in spectacle frames and skin-lightening creams.

C C Sun1.   

Abstract

A total of 507 (M 121, F 386) cases of facial dermatitis were investigated, of whom 308 (M 49, F 259) had eczema confined to the face. The prevalence of positive patch tests was 45% (229/507). Among all the patients, the 2 most frequent allergens were nickel (15.2%) and ammoniated mercury (6.1%), with the incidence of nickel sensitivity in men (20%) being greater than in women (13.7%). 56% of the nickel-positive cases were caused by metal spectacle frames. Taiwan's high number of spectacle-wearers, its subtropical climate and the characteristic oriental facial structure are possibly major contributing factors. Most ammoniated mercury (AM)-sensitive cases resulted from cosmetics. Skin-lightening creams are widely used in Taiwan, but their content is poorly controlled. According to consumer reports, 14.9% (48/322) had applied AM-containing cosmetics. Of all the cosmetics tested for mercury, 2.2% (60/2711) were positive.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436136     DOI: 10.1111/j.1600-0536.1987.tb01483.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  4 in total

1.  The fine scratches of the spectacle frames and the allergic contact dermatitis.

Authors:  In Su Kim; Kwang Ho Yoo; Myeung Nam Kim; Hyuck Ki Hong; Yeon Shik Choi; Young Chang Jo; Beom Joon Kim; Ju Suk Lee
Journal:  Ann Dermatol       Date:  2013-05-10       Impact factor: 1.444

Review 2.  [Facial allergic contact dermatitis. Data from the IVDK and review of literature].

Authors:  A Schnuch; C Szliska; W Uter
Journal:  Hautarzt       Date:  2009-01       Impact factor: 0.751

3.  Mercury levels in locally manufactured Mexican skin-lightening creams.

Authors:  Claudia P Peregrino; Myriam V Moreno; Silvia V Miranda; Alma D Rubio; Luz O Leal
Journal:  Int J Environ Res Public Health       Date:  2011-06-23       Impact factor: 3.390

4.  c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma.

Authors:  Kamini Singh; Jianan Lin; Yi Zhong; Antonija Burčul; Prathibha Mohan; Man Jiang; Liping Sun; Vladimir Yong-Gonzalez; Agnes Viale; Justin R Cross; Ronald C Hendrickson; Gunnar Rätsch; Zhengqing Ouyang; Hans-Guido Wendel
Journal:  J Exp Med       Date:  2019-05-29       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.